COVID-19-Associated Rhino-orbital mucormycosis: Presentation and outcome

We are reporting four accounts of rhino-orbital mucormycosis in patients during and after recovery from SARS-CoV-2 infection. The patients were diagnosed and treated for COVID-19 according to the current treatment protocols, following which they presented with sudden proptosis, ophthalmoplegia, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Saini, Sanchita, Singh, Satya P., Singh, Vinod K., Kumar, Santosh, Singh, Sanskriti, Rajak, Shiv D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032291/
https://www.ncbi.nlm.nih.gov/pubmed/36968777
http://dx.doi.org/10.4103/sjopt.sjopt_154_21
Descripción
Sumario:We are reporting four accounts of rhino-orbital mucormycosis in patients during and after recovery from SARS-CoV-2 infection. The patients were diagnosed and treated for COVID-19 according to the current treatment protocols, following which they presented with sudden proptosis, ophthalmoplegia, and conjunctival injection, confirmed by magnetic resonance imaging and histopathological examination. The patients were treated with intravenous liposomal amphotericin B, and the outcome was observed. Early diagnosis and prompt intervention can substantially reduce the morbidity and mortality rates in these patients.

Ejemplares similares